CompletedNCT06213038
A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)
PHASE1 · 12 planned enrolment
- Countries listed
- 1
- Registry update
- September 11, 2026
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
3 matching trial registrations
- Intervention SKG0106
- Topic Vision ageing
Showing 1–3 of 3. Every record below meets all the filters shown above.
RecruitingNCT06346600
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Phase not reported · 83 planned enrolment
- Countries listed
- 2
- Registry update
- September 1, 2026
RecruitingNCT05986864
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
PHASE1 · PHASE2 · 68 planned enrolment
- Countries listed
- 2
- Registry update
- August 28, 2026